Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Crosbie, Phil
NCT05510674: Safety and Dose Ranging Study for OWL-EVO1 as a Lung Cancer EVOC® Probe (Evolution)	Completed	1	49	Europe	OWL-EVO1, OWL-EVO1 Breath Biopsy Test, D5-ethyl-βD-glucuronide	Owlstone Ltd	Lung Cancer	09/23	09/23
Blane, Sujata
NCT06193239: Diagnostic Accuracy Study for OWL-EVO1 As a Lung Cancer EVOC® Probe (Evolution Phase 2)	Recruiting	2	350	Europe, RoW	OWL-EVO1, OWL-EVO1 Breath Biopsy Test, D5-ethyl-βD-glucuronide	Owlstone Ltd	Lung Cancer	04/25	04/25
NCT05510674: Safety and Dose Ranging Study for OWL-EVO1 as a Lung Cancer EVOC® Probe (Evolution)	Completed	1	49	Europe	OWL-EVO1, OWL-EVO1 Breath Biopsy Test, D5-ethyl-βD-glucuronide	Owlstone Ltd	Lung Cancer	09/23	09/23